Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
Furthermore, rising launch of novel formulations such as long-acting therapies with dosing convenience can drive the market growth
You must use FDA-approved obesity drugs (Wegovy for weight loss, not Ozempic unless treating diabetes)
Dosage varies based on individual needs, but many studies on PCOS and insulin resistance use between 2,000mg and 4,000mg per day
Catching researchers eyes was its uncanny resemblance to human GLP-1, with a superpower: it sticks around in the body far longer
Increasing Insulin Release The GLP-1 pill stimulates your pancreas to release more insulin, but only when your blood sugar is elevated